US · ACON
Aclarion, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Broomfield, CA 94404
- Website
- aclarion.com
Price · as of 2024-12-31
$3.42
Market cap 1.59M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $31,536.99 | +922,034.21% |
| Intrinsic Value(DCF) | $14.90 | +335.67% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $219,217.32 | +6,409,763.27% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $0.00 | $0.00 | |||
| 2022 | $95,659.92 | $1,100,897.04 | $0.00 | $0.00 | $0.00 |
| 2023 | $3,057.21 | $4,999,569.68 | $66,472.89 | $0.00 | $0.00 |
| 2024 | $37.26 | $31,536.99 | $0.00 | $0.00 | $219,217.32 |
AI valuation
Our deep-learning model estimates Aclarion, Inc.'s (ACON) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $31,536.99
- Current price
- $3.42
- AI upside
- +922,034.21%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$14.90
+335.67% upside
Graham-Dodd
—
— upside
Graham Formula
$219,217.32
+6,409,763.27% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ACON | Aclarion, Inc. | $3.42 | 1.59M | +922,034% | +336% | — | +6,409,763% | -0.01 | 0.04 | 0.77 | 0.07 | — | -0.11 | -183.81% | -12057.23% | -15293.78% | -5777.80% | 10310.16% | -305.15% | 0.00 | -10.30 | 0.71 | 0.41 | 0.07 | -9062.00% | -3936.00% | 4851.00% | -15922.34% | -4.57 | 10460.70% | 0.00% | 0.00% | 1589.28% | 0.08 | 0.07 | -9.15 | -42.51 |
| BFRG | Bullfrog AI Holdings, Inc… | $0.58 | 5.64M | +5,971% | — | — | — | -2.12 | 2.99 | — | -1.35 | — | 2.99 | 0.00% | — | — | -185.12% | 2867.39% | -167.95% | 0.00 | -398.52 | 9.43 | 9.24 | 0.78 | -449.00% | -10000.00% | -652.00% | -37.80% | -9.54 | 2223.04% | 0.00% | 0.00% | 18.94% | -1.30 | -1.68 | — | 7.68 |
| BNBX | BNB Plus Corp. | $0.71 | 910.41K | — | — | — | — | -0.10 | 0.67 | 0.73 | -0.01 | — | 0.67 | 39.26% | -750.92% | -709.46% | — | — | — | 0.08 | — | 0.91 | 0.77 | 0.09 | — | — | — | -826.25% | -5.08 | — | 0.00% | 0.00% | 0.00% | 0.00 | -0.01 | 0.04 | -130.76 |
| CMND | Clearmind Medicine Inc. | $1.13 | 154.43K | — | — | — | — | -0.08 | 0.25 | — | 0.94 | — | 0.27 | 0.00% | — | — | -180.28% | 180.16% | -58.05% | 1.49 | -290.07 | 1.22 | 1.21 | 0.58 | -5494.00% | — | -189.00% | -1590.11% | -0.97 | 150.51% | 0.00% | 0.00% | 0.00% | 0.62 | 0.74 | — | -9.25 |
| ENSC | Ensysce Biosciences, Inc. | $0.62 | 1.48M | +2,572,138,798% | +223% | — | — | -1.10 | 2.36 | 1.68 | -0.83 | — | 2.36 | -38.57% | -129.17% | -153.30% | -471.83% | 16069.72% | -192.33% | 0.08 | -5.22 | 2.42 | 1.64 | 0.48 | -256.00% | 13353.00% | 6959834645.00% | -85550186.53% | -3399198.17 | 17914756446.99% | 3306.75% | -3630.90% | 3340.18% | -0.83 | 0.00 | 1.07 | -32.39 |
| KZIA | Kazia Therapeutics Limite… | $8.45 | 13.69M | +90% | -63% | — | +12,468% | -0.63 | -1.56 | 309.03 | -0.68 | — | -1.38 | 100.00% | -33850.00% | -49290.48% | 226.03% | 112.59% | -149.76% | -0.05 | — | 0.35 | 0.32 | 0.30 | -6564.00% | -9818.00% | 3859.00% | -102.30% | -0.94 | 114.02% | 0.00% | 0.00% | 22.54% | -0.64 | -0.68 | 215.01 | -40.14 |
| MSPR | MSP Recovery, Inc. | $0.04 | 537.2K | +14,182% | +17,977% | — | — | -0.01 | 0.14 | 0.76 | -1.22 | -0.01 | -0.01 | 47.36% | -6982.79% | -1975.45% | -834.83% | -139.81% | -61.30% | 7.90 | -3.03 | 0.01 | 0.01 | -1.20 | 12779.00% | 13685.00% | -6014.00% | -119.26% | -0.01 | -1.83% | 0.00% | 0.00% | 0.00% | -0.62 | -47.84 | 43.63 | -3.28 |
| SILO | Silo Pharma, Inc. | $0.37 | 2.92M | +5,090% | +86% | — | — | -1.09 | 0.95 | 66.36 | 0.52 | — | 1.00 | 91.90% | -6526.44% | -6092.59% | -78.37% | 266.27% | -57.96% | 0.00 | -925.59 | 4.29 | 4.28 | 0.89 | -83.00% | 0.00% | 1890.00% | -80.13% | -2.32 | 216.94% | 0.00% | 0.00% | 11.59% | 0.49 | 0.60 | -31.84 | -2.88 |
| SNGX | Soligenix, Inc. | $1.18 | 11.9M | — | — | — | — | -0.48 | 0.96 | — | 0.25 | — | 0.96 | 0.00% | — | — | -248.97% | 387.20% | -88.11% | 0.36 | — | 1.82 | 1.61 | 0.67 | -6066.00% | — | -233.00% | -213.60% | -1.73 | 361.77% | 0.00% | 0.00% | 35.16% | 0.25 | 0.29 | — | -38.99 |
About Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
- CEO
- Brent Ness
- Employees
- 5
- Beta
- 1.44
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($14.90 ÷ $3.42) − 1 = +335.67% (DCF, example).